1Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract,2010,87:4-14.
2Brem H,Tomic-Canic M.Cellular and molecular basis of wound healing in diabetes.J Clin Invest,2007,117:1219-1222.
3Graiani G,Emanueli C,Desortes E,et al.Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice.Diabetologia,2004,47:1047-1054.
4Sayan H,Ozacmak VH,Guven A,et al.Erythropoietin stimulates wound healing and angiogenesis in mice.J Invest Surg,2006,19:163-173.
5Luo JD,Wang YY,Fu WL,et al.Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.Circulation,2004,110:2484-2493.
6Tie L,Li XJ,Wang X,et al.Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes.Am J Physiol Endocrinol Metab,2009,296:E1423-E1429.
7Ojha N,Roy S,He G,et al.Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing.Free Radic Biol Med,2008,44:682-691.
8Merrell JG,McLaughlin SW,Tie L,et al.Curcumin-loaded poly(epsilon-caprolactone) nanofibres:diabetic wound dressing with anti-oxidant and anti-inflammatory properties.Clin Exp Pharmacol Physiol,2009,36:1149-1156.
9Lobmann R,Ambrosch A,Schultz G,et al.Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.Diabetologia,2002,45:1011-1016.
10Botusan IR,Sunkari VG,Savu O,et al.Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice.Proc Natl Acad Sci USA,2008,105:19426-19431.
